NCT02052375View on ClinicalTrials.gov

A Study To Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of ASP2408 After Multiple Dose Subcutaneous Injections in Patients With Rheumatoid Arthritis on Methotrexate

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

June 30, 2012

Primary Completion Date

December 31, 2013

Study Completion Date

December 31, 2013

Conditions
Rheumatoid ArthritisPharmacokinetics of ASP2408
Interventions
DRUG

ASP2408

subcutaneous injection

DRUG

Placebo

subcutaneous injection

Trial Locations (3)

16635

Altoona Center for Clinical Research, Duncansville

36207

Pinnacle Research Group, LLC, Anniston

75231

Metroplex Clinical Research Center, LLC, Dallas

All Listed Sponsors
lead

Astellas Pharma Global Development, Inc.

INDUSTRY

NCT02052375 - A Study To Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of ASP2408 After Multiple Dose Subcutaneous Injections in Patients With Rheumatoid Arthritis on Methotrexate | Biotech Hunter | Biotech Hunter